on 28 May 2024
Last Applicant/ Owned by
100 Pennsylvania Avenue, #310
Framingham
MA
01701
Serial Number
97030469 filed on 16th Sep 2021
Registration Number
7402522 registered on 28th May 2024
Correspondent Address
Sara M. Bauer
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for Read More
Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences
20th Oct 2021
20th Oct 2021
Consulting services in the fields of pharmaceutical research and development, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development, and quality control for others in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting in the fields of pharmaceutical research and development, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; Consulting services for others in the field of design, planning, and implementation project management of clinical trial development and clinical trials; Providing technical consulting services in the nature of advising on the testing, analysis and evaluation of the goods of others to determine conformity with certification standards; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; Scientific research consulting in the field of clinical trial development and clinical trials
20th Oct 2021
20th Oct 2021
Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the fields of pharmaceuticals and biopharmaceuticals and related technologies, specifically, business consulting with respect to clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, assisting others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
20th Oct 2021
20th Oct 2021
No 97030469
No Service Mark
No 120283.00137
No
No
No
No
No
No
No
No
26.05.02 -
Plain single line triangles
26.05.03 -
Incomplete triangles (must have two angles)
26.05.12 -
Triangles with bars, bands and lines
26.05.13 -
Two Triangles
26.05.21 -
Triangles that are completely or partially shaded
26.17.13 -
Letters or words underlined and/or overlined by one or more strokes or lines
26.19.05 -
Prisms and pyramids
Status Date | Action Taken |
---|---|
28th May 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
28th May 2024 | REGISTERED-PRINCIPAL REGISTER |
24th Apr 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
24th Apr 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
20th Apr 2024 | STATEMENT OF USE PROCESSING COMPLETE |
20th Apr 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
02th Apr 2024 | USE AMENDMENT FILED |
02th Apr 2024 | TEAS STATEMENT OF USE RECEIVED |
26th Oct 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
26th Oct 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |